These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6244873)

  • 1. Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir.
    Boulter EA; Thornton B; Bauer DJ; Bye A
    Br Med J; 1980 Mar; 280(6215):681-3. PubMed ID: 6244873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral chemotherapy of fatal B virus (herpesvirus simiae) infection.
    Zwartouw HT; Humphreys CR; Collins P
    Antiviral Res; 1989; 11(5-6):275-83. PubMed ID: 2552914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postexposure immunoprophylaxis against B virus infection.
    Boulter EA; Zwartouw HT; Thornton B
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):746. PubMed ID: 6279227
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of herpes virus isolates from acyclovir clinical trials.
    Collins P; Appleyard G; Oliver NM
    Am J Med; 1982 Jul; 73(1A):380-2. PubMed ID: 6285727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drug.
    Brigden D; Fiddian P; Rosling AE; Ravenscroft T
    Antiviral Res; 1981 Nov; 1(4):203-12. PubMed ID: 6280605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency of Herpes Simiae (B virus) in rabbits.
    Vizoso AD
    Br J Exp Pathol; 1975 Dec; 56(6):489-94. PubMed ID: 177039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B virus (Herpesvirus simiae) and human infection.
    Benson PM; Malane SL; Banks R; Hicks CB; Hilliard J
    Arch Dermatol; 1989 Sep; 125(9):1247-8. PubMed ID: 2549884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effect of acyclovir on pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.
    Thiry E; Vindevogel H; Leroy P; Pastoret PP; Schwers A; Brochier B; Anciaux Y; Hoyois P
    Ann Rech Vet; 1983; 14(3):239-45. PubMed ID: 6318645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.
    Sicher SE; Oh JO
    Antimicrob Agents Chemother; 1981 Oct; 20(4):503-7. PubMed ID: 6282195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1).
    Cohen JI; Davenport DS; Stewart JA; Deitchman S; Hilliard JK; Chapman LE;
    Clin Infect Dis; 2002 Nov; 35(10):1191-203. PubMed ID: 12410479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses.
    Cupps TR; Straus SE; Waldmann TA
    Am J Med; 1981 Apr; 70(4):882-6. PubMed ID: 6259942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of life-threatening Epstein-Barr virus infection with acyclovir.
    Sullivan JL; Byron KS; Brewster FE; Sakamoto K; Shaw JE; Pagano JS
    Am J Med; 1982 Jul; 73(1A):262-6. PubMed ID: 6285718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
    Trousdale MD; Dunkel EC; Nesburn AB
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure immunoprophylaxis against B virus (Herpesvirus simiae) infection.
    Boulter EA; Zwartouw HT; Thornton B
    Br Med J (Clin Res Ed); 1981 Dec; 283(6305):1495-7. PubMed ID: 6275934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan.
    Davenport DS; Johnson DR; Holmes GP; Jewett DA; Ross SC; Hilliard JK
    Clin Infect Dis; 1994 Jul; 19(1):33-41. PubMed ID: 7948555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
    Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.
    Carr JA; Rogerson J; Mulqueen MJ; Roberts NA; Booth RF
    J Virol; 1997 Oct; 71(10):7799-803. PubMed ID: 9311865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir.
    Lancet; 1981 Oct; 2(8251):845-6. PubMed ID: 6116957
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylaxis against B virus infection?
    Brown D; Cropper L; Lees D; Gardner S
    BMJ; 1988 Nov; 297(6659):1332. PubMed ID: 2849494
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity in Herpes simiae (B virus) and some antigenic relationships in the herpes group.
    Vizoso AD
    Br J Exp Pathol; 1974 Oct; 55(5):471-7. PubMed ID: 4375486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.